Self-expanding polyethylene terephthalate and polytetrafluoroethylene (PTFE)-covered stents have been shown to decrease the need for repeat procedures in the iliac artery. [33] Similar to surgical ...
NATICK, Mass., Boston Scientific Corporation today announced that it has completed enrollment in the ORION clinical trial, which is designed to evaluate the Company's EPIC™ Self-Expanding Nitinol ...
MOBILITY Trial Demonstrated Absolute Pro to be Safe and Effective in Patients with Peripheral Artery Disease in the Lower Extremities Abbott Park, Illinois — Abbott today announced that the U.S. Food ...
As you may be aware, the heart’s arteries are not rigid pipes; they’re living structures that twist, flex, constrict, expand, ...
Cordis announced the FDA has approved its self-expanding vascular stent designed for transradial peripheral procedures in the iliac and superficial femoral arteries. The self-expanding stent ...
Boston Scientific Corp. has announced it has received FDA approval and market launch of its Epic vascular self-expanding stent system, according to a news release. Boston Scientific said the Epic ...
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/9r4nlm/medipoint) has announced the addition of the "MediPoint: Peripheral ...
The US Food and Drug Administration (FDA) has approved Abbott's Absolute Pro Vascular Self-Expanding Stent System for the treatment of iliac artery disease, a form of peripheral artery disease (PAD) ...
The treatment of patients with peripheral arterial disease has evolved tremendously since the early 1960s, when Charles Dotter first successfully revascularized a superficial femoral artery occlusion ...